Drug Overview
In the field of Gastroenterology and clinical toxicology, managing the accidental ingestion of harmful substances has historically involved medications designed to induce vomiting. Ipecac syrup is a traditional BOTANICAL EXTRACT and an Emetic, falling under the Gastroenterology category for its direct action on the digestive system. For decades, it was a staple in household medicine cabinets and emergency rooms as a first-line response to poisoning. However, it is primarily considered a legacy drug today. Modern medical guidelines have largely phased out its use in favor of safer, more effective gastrointestinal decontamination methods, though understanding its profile remains essential for historical context and recognizing patterns of misuse.
- Generic Name / Active Ingredient: Ipecac syrup (contains emetine and cephaeline)
- US Brand Names: Historically available as generic Ipecac Syrup (now largely discontinued)
- Drug Category: Gastroenterology / Toxicology
- Drug Class: Emetic
- Route of Administration: Oral liquid
- FDA Approval Status: Previously FDA-Approved for over-the-counter (OTC) use; however, the FDA has since severely restricted it, and major medical boards actively advise against its use.
What Is It and How Does It Work? (Mechanism of Action)

Ipecac syrup is derived from the dried roots of the Carapichea ipecacuanha plant. Its biological activity is driven by two primary ALKALOID compounds: emetine and cephaeline. This natural SMALL MOLECULE formulation acts as a powerful emetic, meaning it forces the body to vomit.
The mechanism of action is twofold, operating on both a local and a neurological level. Locally, when the syrup is swallowed, the alkaloids act as severe irritants to the gastric mucosa (the stomach lining). This intense irritation sends distress signals via the vagus nerve to the brain.
Systemically, the alkaloids are quickly absorbed into the bloodstream, where they travel to the brain and stimulate the Chemoreceptor Trigger Zone (CTZ). The CTZ is a specific area in the medulla oblongata responsible for detecting toxins in the blood and spinal fluid. Once the CTZ is activated by the ipecac alkaloids, it directly triggers the brain’s vomiting center. This coordinated response forces the diaphragm and abdominal muscles to contract violently while the esophageal sphincter relaxes, forcefully expelling the stomach’s contents to prevent the absorption of ingested toxins.
FDA-Approved Clinical Indications
Primary Indication
Historically, the primary indication for ipecac syrup was the rapid induction of vomiting in the conscious patient following the recent ingestion of specific toxic substances, poisons, or drug overdoses.
Primary Gastroenterology Indications
- Gastric Decontamination (Legacy Use): Historically used in emergency gastroenterology and toxicology to physically empty the stomach of toxic agents before they could pass into the intestines and be absorbed into the systemic circulation. This was meant to restore digestive and systemic safety after an accidental poisoning.
Other Approved & Off-Label Uses
While its legitimate medical uses have become obsolete, healthcare providers must be aware of its off-label misuse:
- Bulimia Nervosa (Misuse/Abuse): Ipecac syrup has a documented history of dangerous off-label misuse by individuals suffering from eating disorders who use it to induce vomiting after binge eating. This chronic misuse leads to severe cardiac and muscular toxicity.
- Munchausen Syndrome by Proxy: Tragically, it has been used off-label in cases of medical child abuse to simulate chronic gastrointestinal illness in victims.
Dosage and Administration Protocols
Note: The following represents historical dosing guidelines. Ipecac is no longer recommended for routine clinical or home use.
When it was actively utilized, ipecac syrup was administered orally, always followed by a large glass of water (8 to 16 ounces) to facilitate the physical action of vomiting. It was never administered on an empty stomach without accompanying fluids.
| Indication | Standard Dose | Frequency |
| Induction of Emesis (Adults & Teens) | 15 to 30 ml orally | Once. May repeat a single 15 ml dose after 20-30 mins if vomiting does not occur. |
| Induction of Emesis (Children 1-12 years) | 15 ml orally | Once. May repeat a single 15 ml dose after 20-30 mins if vomiting does not occur. |
| Induction of Emesis (Infants 6-12 months) | 5 to 10 ml orally | Strictly under professional medical supervision only. Do not repeat. |
Dose Adjustments and Special Populations:
- Pediatric Precautions: Historically strictly contraindicated in infants under 6 months of age due to a high risk of aspiration and underdeveloped airway protective reflexes.
- Hepatic/Renal Impairment: Chronic use leads to cumulative toxicity. If an initial dose fails to produce vomiting, medical intervention (gastric lavage) was historically required to remove the ipecac itself, as retained alkaloids cause systemic toxicity.
Dosage must be individualized by a qualified healthcare professional.
Clinical Efficacy and Research Results
Current toxicological and gastroenterology research guidelines spanning 2020 to 2026 universally reflect the paradigm shift away from ipecac syrup. Modern clinical study data demonstrates that ipecac is no longer considered an efficacious or safe intervention for poisonings.
Recent meta-analyses of historical poison control data reveal that ipecac only removes about 30 percent of stomach contents on average, which is clinically insufficient to reliably prevent drug or toxin absorption. Furthermore, modern research emphasizes that administering ipecac actively delays the administration and effectiveness of vastly superior therapies, primarily oral activated charcoal. Because ipecac causes prolonged, uncontrollable vomiting (often lasting for hours), emergency physicians cannot safely administer activated charcoal or oral antidotes, as the patient will simply vomit them back up.
Due to this lack of clinical efficacy, combined with the risk of severe complications, the American Academy of Pediatrics (AAP) and global poison control centers have formally advised against stocking or using ipecac syrup.
Safety Profile and Side Effects
There is no formal FDA “Black Box Warning” for ipecac syrup, largely because it was an OTC legacy drug predating modern warning label systems. However, major clinical warnings exist regarding its potential to cause severe, life-threatening complications, particularly with inappropriate or chronic use.
Common Side Effects (Occurring in >10% of patients)
- Prolonged, uncontrollable vomiting (lasting longer than 1 hour)
- Severe lethargy and drowsiness (especially in young children)
- Diarrhea and abdominal cramping
- Mild gastrointestinal upset
Serious Adverse Events
- Aspiration Pneumonia: The inhalation of stomach contents into the lungs during vomiting, which can be fatal.
- Bowel or Esophageal Perforation: Violent retching can cause Mallory-Weiss tears (bleeding in the esophagus) or full physical ruptures of the gastrointestinal tract.
- Cardiotoxicity: The emetine compound is highly toxic to the heart muscle. Chronic misuse (such as in eating disorders) causes fatal arrhythmias, cardiomyopathy, and sudden cardiac arrest.
- Neuromuscular Weakness: Accumulation of alkaloids leads to severe myopathy (muscle weakness) and tremors.
Management Strategies
If ipecac is ingested and vomiting does not stop, supportive care is required. This involves intravenous (IV) fluid replacement to fix severe electrolyte imbalances caused by fluid loss. If ipecac is accidentally administered to a patient who ingested a caustic chemical, immediate airway monitoring is vital, as the chemical will burn the esophagus a second time upon coming back up.
Research Areas
Current clinical research in gastrointestinal decontamination has completely pivoted away from emetics like ipecac. Instead, modern gastroenterology and toxicology research focuses on the gut microbiome’s role in neutralizing certain toxins, and the optimization of non-emetic decontamination protocols. Active clinical research focuses on advancing TARGETED THERAPY antidotes, refining the use of high-surface-area activated charcoal to bind toxins directly in the gut lumen, and utilizing whole-bowel irrigation (using polyethylene glycol solutions) to flush sustained-release toxic drugs through the GI tract without risking esophageal damage or aspiration associated with vomiting.
Disclaimer: This information is for educational and historical purposes only and is not medical advice. Ipecac syrup is no longer recommended for home or clinical use. In the event of a poisoning or medical emergency, contact emergency services or a Poison Control Center immediately. Never attempt to induce vomiting at home unless explicitly directed by a medical professional.
Patient Management and Clinical Protocols
Pre-treatment Assessment
Because ipecac is essentially obsolete, current protocol dictates that patients or caregivers must contact a Poison Control Center immediately before taking any action. If evaluating a patient who has already taken ipecac, physicians assess:
- Baseline Diagnostics: Evaluating the patient’s airway, breathing, and circulation.
- Toxin Identification: Identifying what was ingested. Ipecac is absolutely contraindicated if the patient swallowed corrosive substances (acids, lye, bleach) or volatile hydrocarbons (gasoline, kerosene), as vomiting these will destroy the esophagus or cause instant, fatal lung damage.
- Neurological Screening: Ensuring the patient has a fully intact gag reflex and is completely conscious to prevent aspiration.
Monitoring and Precautions
- Vigilance: Patients who have vomited extensively must be monitored for signs of dehydration, electrolyte shifts (low potassium or sodium), and cardiac rhythm abnormalities via an EKG, particularly if chronic abuse is suspected.
- Lifestyle: In cases where ipecac was misused for weight control, psychiatric intervention, nutritional rehabilitation, and long-term cardiac monitoring are mandatory components of the patient’s recovery protocol.
Do’s and Don’ts
- DO call your local Poison Control Center or emergency services immediately if you suspect a poisoning, rather than attempting home remedies.
- DO safely dispose of any old bottles of ipecac syrup remaining in your household medicine cabinets.
- DON’T ever administer ipecac syrup to someone who is drowsy, unconscious, or having seizures.
- DON’T use emetics for the ingestion of cleaning products, batteries, or fuels under any circumstances.
Legal Disclaimer
The medical information provided in this guide is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the direct advice of your physician, specialized gastroenterologist, local Poison Control Center, or other qualified healthcare provider with any questions you may have regarding a medical emergency, poisoning, or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read in this material.